Filing Details

Accession Number:
0001140361-15-019554
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-14 11:54:52
Reporting Period:
2015-05-12
Filing Date:
2015-05-14
Accepted Time:
2015-05-14 11:54:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380184 Zsolt Harsanyi 400 Professional Dr, Suite 400
Gaithersburg MD 20879
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-05-12 13,600 $11.67 32,700 No 4 M Direct
Common Stock Disposition 2015-05-12 13,600 $30.09 19,100 No 4 S Direct
Common Stock Acquisiton 2015-05-12 4,800 $14.66 23,900 No 4 M Direct
Common Stock Disposition 2015-05-12 4,800 $30.01 19,100 No 4 S Direct
Common Stock Acquisiton 2015-05-12 2,400 $14.25 21,500 No 4 M Direct
Common Stock Disposition 2015-05-12 2,400 $30.01 19,100 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2015-05-12 13,600 $0.00 13,600 $11.67
Common Stock Stock Option Disposition 2015-05-12 4,800 $0.00 4,800 $14.66
Common Stock Stock Option Disposition 2015-05-12 2,400 $0.00 2,400 $14.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-05-21 2019-05-21 No 4 M Direct
2,400 2013-05-17 2019-05-17 No 4 M Direct
4,800 2014-05-23 2020-05-22 No 4 M Direct
Footnotes
  1. Consists of an option granted under the company's stock incentive plan on May 21, 2009.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.23, inclusive.
  3. Consists of an option granted under the company's stock incentive plan on May 17, 2012.
  4. Consists of an option granted under the company's stock incentive plan on May 23, 2013.
  5. All options vested in three equal installments on the anniversary date of the grant.